KUALA LUMPUR: Affin Hwang Capital Research believes that CIMB Group
remains on track for an earnings recovery and the upcoming second quarter results could provide further confirmations.
“With its share price trading at distressed level, we believe that downside risks may be limited. Maintain buy on CIMB with our target price of RM5,” it said.
Already a subscriber? Log in.
Subscribe now and receive FREE sooka plan for 1 month.
T&C applies.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
